Annual Drug Patent Expirations for VEMLIDY
Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
Drug patent litigation for VEMLIDY.
This drug has sixty-eight patent family members in thirty-four countries.
The generic ingredient in VEMLIDY is tenofovir alafenamide fumarate. One supplier is listed for this compound. Additional details are available on the tenofovir alafenamide fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
